RepIntel reimagines pharmaceutical outreach as a core layer of global health infrastructure, converting field operations into a responsive intelligence network that channels lifesaving therapies to the patients and populations who need them most.

New York, NY, United States, October 17, 2025 /MarketersMEDIA/ — Aletheia Capital Endeavours (ACE) today announced the launch of RepIntel, a precision field-intelligence platform designed to close one of healthcare’s most persistent gaps: the failure of lifesaving therapies to reach the patients they were created for. 

The company was founded by Gavin Perri, the New York impresario and Executive Chairman of Aletheia Capital Endeavours, and Filomena Di Luise, Senior Executive Manager at a Fortune 100 technology firm, who will serve as President and Chief Operating Officer for RepIntel. Di Luise brings enterprise-scale infrastructure expertise to the venture’s leadership team. 

Drawing on frameworks that redefined political mobilization, RepIntel translates those same principles of precision targeting, coordinated field orchestration, and real-time intelligence into the final mile of healthcare delivery. 

“Every year, scientific breakthroughs transform what medicine can do. Yet millions still go without the treatments that could change or save their lives,” said Gavin Perri, Executive Chairman of Aletheia Capital Endeavours. “RepIntel is designed to solve that systemic failure. By transforming field operations into an adaptive intelligence network, we’re building the connective tissue that allows innovation to translate into real-world impact.” 

RepIntel unites vast healthcare datasets with ground-level decision-making, enabling pharmaceutical teams to identify unmet needs, prioritize underserved populations, and orchestrate outreach with surgical precision. Its first deployments target highly regulated markets, where the speed, accuracy, and equity of distribution directly determine patient outcomes. 

The launch marks ACE’s first flagship technology venture and reflects a broader thesis: that the most resilient and equitable healthcare systems will be those that harness distributed intelligence, empowering those closest to patients to guide the flow of treatments and resources in real time. In doing so, RepIntel establishes the operational layer needed to ensure that scientific progress becomes societal progress.

About the company: About Aletheia Capital Endeavours:
Aletheia Capital Endeavours (ACE) is a New York-based venture studio and applied think
tank architecting the cultural, technological, and intellectual systems that shape the
future. Its work spans entertainment ventures and large-scale philanthropic initiatives,
often structured as thesis-oriented coalitions of high-net-worth partners that align social
impact with strategic tax efficiency and legacy-oriented wealth planning.

About RepIntel:
RepIntel is a precision field-intelligence platform incubated by ACE, designed as a critical
layer in the delivery architecture of modern healthcare. It enables pharmaceutical and
healthcare institutions to deploy campaign-grade targeting, adaptive outreach, and
distributed decision-making to bridge the last-mile gap, ensuring that medical
breakthroughs reach patients with the speed, precision, and equity the 21st century
demands.

Contact Info:
Name: Public Relations
Email: Send Email
Organization: Aletheia Capital Endeavours
Website: https://www.repintel.com

Release ID: 89172719

In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]